Anthropic's Claude AI system identified a novel gene-editing mechanism called ART after scanning over 200,000 reverse transcriptases in 21 hours, with researchers subsequently validating the discovery in laboratory tests. The finding adds to expanding CRISPR innovation, as gene-editing applications broaden beyond medicine into multiple biotech sectors, driving commercialization opportunities through 2030.
Quwwaa is your AI news butler — a personalized brief and assistant for the stories you care about.
See more on Quwwaa — create a free account